Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NIKOLAOS PYRSOPOULOS

Allopathic & Osteopathic Physicians Internal Medicine Transplant Hepatology

NPI
1932131075
CMS profile
41905
Location
NEW YORK, NY

General Payments · PY2018–2024

$174,935.98

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$19,034.17

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $50,330.64 24
PY2019 $40,433.47 16
PY2020 $38,601.00 6
PY2022 $3,617.92 3
PY2023 $22,918.78 7
PY2024 $19,034.17 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ardelyx, Inc. $18.28 10/30/2024 Food and Beverage Undisputed 01/23/2026 1146701892 CMS
Ferring Pharmaceuticals Inc. $15.14 09/27/2024 Food and Beverage Undisputed 01/23/2026 1137503946 CMS
Gilead Sciences, Inc. $15.75 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133827765 CMS
Gilead Sciences, Inc. $17.15 11/22/2024 Food and Beverage Undisputed 01/23/2026 1133827767 CMS
Intercept Pharmaceuticals, Inc. $14.37 10/02/2024 Food and Beverage Undisputed 01/23/2026 1113640253 CMS
Intercept Pharmaceuticals, Inc. $15.79 12/12/2024 Food and Beverage Undisputed 01/23/2026 1113640255 CMS
Ipsen Biopharmaceuticals, Inc $52.34 11/17/2024 Food and Beverage Undisputed 01/23/2026 1091991603 CMS
Madrigal Pharmaceuticals $1,763.00 09/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144179423 CMS
Madrigal Pharmaceuticals $167.47 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144179425 CMS
Madrigal Pharmaceuticals $342.05 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144179427 CMS
Madrigal Pharmaceuticals $4,935.00 09/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144179429 CMS
Madrigal Pharmaceuticals $127.00 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144179431 CMS
Madrigal Pharmaceuticals $80.91 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144179433 CMS
Madrigal Pharmaceuticals $226.86 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144179435 CMS
Madrigal Pharmaceuticals $186.86 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144179437 CMS
Madrigal Pharmaceuticals $77.39 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144179439 CMS
Madrigal Pharmaceuticals $94.62 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144179441 CMS
Madrigal Pharmaceuticals $226.26 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1144179443 CMS
Madrigal Pharmaceuticals $133.13 10/14/2024 Food and Beverage Undisputed 01/23/2026 1144179445 CMS
Madrigal Pharmaceuticals $4,583.00 10/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144179447 CMS
Madrigal Pharmaceuticals $80.84 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1144179449 CMS
Madrigal Pharmaceuticals $199.83 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1144179451 CMS
Madrigal Pharmaceuticals $500.95 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1144179453 CMS
Madrigal Pharmaceuticals $141.66 10/15/2024 Food and Beverage Undisputed 01/23/2026 1144179455 CMS
Madrigal Pharmaceuticals $3,173.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144179457 CMS
Madrigal Pharmaceuticals $249.27 10/15/2024 Travel and Lodging Undisputed 01/23/2026 1144179459 CMS
Madrigal Pharmaceuticals $147.24 11/16/2024 Food and Beverage Undisputed 01/23/2026 1144179461 CMS
Madrigal Pharmaceuticals $18.09 12/13/2024 Food and Beverage Undisputed 01/23/2026 1144179463 CMS
Madrigal Pharmaceuticals $1,410.00 12/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1144179465 CMS
Medtronic, Inc. $20.92 04/11/2024 Food and Beverage Undisputed 01/23/2026 1119551836 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.